Meir Medical Center

Meir Medical Center logo
Ownership
Private
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Etoricoxib Versus Gabapentin for Knee Arthroscopy

Phase 4
Completed
Conditions
Knee Arthroscopy
Interventions
Drug: Gabapentin, Etoricoxib, Sugar pill
First Posted Date
2008-11-27
Last Posted Date
2008-11-27
Lead Sponsor
Meir Medical Center
Target Recruit Count
75
Registration Number
NCT00799149
Locations
🇮🇱

Meir Medical Center, Kfar-Saba, Israel

Study Assessing the Efficacy of Etoricoxib in Female Patients With Fibromyalgia

Phase 4
Conditions
Fibromyalgia
Interventions
Drug: etoricoxib
First Posted Date
2008-09-19
Last Posted Date
2012-08-10
Lead Sponsor
Meir Medical Center
Target Recruit Count
80
Registration Number
NCT00755521
Locations
🇮🇱

Department of Medicine 'D', Meir Medical Center, Kfar-Saba, Israel

Influence of Plasma Rich in Growth Factors (PRGF) on Healing of Medial Collateral Ligament (MCL) Tear

First Posted Date
2008-08-29
Last Posted Date
2011-07-12
Lead Sponsor
Meir Medical Center
Target Recruit Count
50
Registration Number
NCT00743886
Locations
🇮🇱

Meir Medical Center, Kfar Saba, Israel

Platelet-rich Plasma (PRP) Treatment for Medial Retinaculum Tear Post Medial Patellar Dislocation

First Posted Date
2008-08-29
Last Posted Date
2011-07-12
Lead Sponsor
Meir Medical Center
Target Recruit Count
50
Registration Number
NCT00743873
Locations
🇮🇱

Meir medical center, Kfar Saba, Israel

Platelet Rich Plasma (PRP) as a Treatment for ACHILLES Tendon Tears

Phase 2
Completed
Conditions
Achilles Tendon Tear
Interventions
Biological: placebo
Biological: PRGF
First Posted Date
2008-08-08
Last Posted Date
2013-10-24
Lead Sponsor
Meir Medical Center
Target Recruit Count
50
Registration Number
NCT00731068

Preparation Rich in Growth Factors (PRGF) Treatment for Osteoarthritis of the Knee

First Posted Date
2008-08-06
Last Posted Date
2011-07-12
Lead Sponsor
Meir Medical Center
Target Recruit Count
60
Registration Number
NCT00728611
Locations
🇮🇱

Meir Medical Center, Kfar Saba, Israel

Plasma Rich in Growth Factors (PRGF) Treatment for Muscle Tear

Phase 2
Completed
Conditions
Muscle Tear
Interventions
Biological: PRGF
Biological: Placebo
First Posted Date
2008-07-31
Last Posted Date
2011-07-12
Lead Sponsor
Meir Medical Center
Target Recruit Count
50
Registration Number
NCT00726245
Locations
🇮🇱

Meir Medicak Center, Kfar Saba, Israel

Treatment of ATFL Tears With PRP

Not Applicable
Completed
Conditions
Soft Tissue Healing
Interventions
Biological: PGRF
Biological: placebo saline
First Posted Date
2008-07-31
Last Posted Date
2011-07-12
Lead Sponsor
Meir Medical Center
Target Recruit Count
30
Registration Number
NCT00725907
Locations
🇮🇱

Meir Medical Center, Kfar Saba, Israel

USF Hemostasis: USage of HemCon for Femoral Hemostasis After Percutaneous Procedures

Phase 4
Completed
Conditions
Coronary Angiography
Interventions
Device: HemCon bandage
First Posted Date
2008-07-16
Last Posted Date
2011-08-16
Lead Sponsor
Meir Medical Center
Target Recruit Count
278
Registration Number
NCT00716365
Locations
🇮🇱

Meir Medical Center, Kfar-Saba, Israel

A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin

First Posted Date
2008-05-26
Last Posted Date
2012-03-19
Lead Sponsor
Meir Medical Center
Target Recruit Count
1000
Registration Number
NCT00684528
Locations
🇮🇱

Clalit Health services center, Tel Aviv, Israel

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy